The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research

by Eline A.M. Ruigrok, Wytske M. van Weerden, Julie Nonnekens, Marion de Jong
Published 2019-10-01

Cellular dosimetry of [177Lu]Lu-DOTA-[Tyr3]octreotate radionuclide therapy: the impact of modeling assumptions on the correlation with in vitro cytotoxicity

by Giulia Tamborino, Marijke De Saint-Hubert, Lara Struelens, Dayana C. Seoane, Eline A. M. Ruigrok, An Aerts, Wiggert A. van Cappellen, Marion de Jong, Mark W. Konijnenberg, Julie Nonnekens
Published 2020-02-01